Ozempic

Novo Nordisk's New Weight Loss Pill Shows Promising Results

The Danish pharmaceutical giant's experimental drug, amycretin, demonstrates significant weight loss in early trials, potentially outperforming its predecessors, Wegovy and Ozempic.